Loading...
Rivaroxaban
India Pharmaceutical Trade Intelligence
Who Supplies Rivaroxaban to India from AUSTRALIA
India's rivaroxaban imports from AUSTRALIA total $28.2K across 20 shipments from 5 foreign suppliers. BILCARE GCS INC. leads with $9.6K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MANKIND PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for rivaroxaban — a diversified sourcing base with multiple active suppliers from AUSTRALIA.
Top foreign suppliers (AUSTRALIA) — Ranked by import value
BILCARE GCS INC. is the leading Rivaroxaban supplier from AUSTRALIA to India, with import value of $9.6K across 8 shipments. The top 5 suppliers — BILCARE GCS INC., PRO PHARMACEUTICALS GROUP PTY LTD, PRO PHARMACEUTICALS GROUP, M/S. BILCARE GCS INC., NEWLIFE MEDICALS (USA). INC. — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (AUSTRALIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BILCARE GCS INC. | $9.6K | 8 | 34.1% |
| 2 | PRO PHARMACEUTICALS GROUP PTY LTD | $5.7K | 3 | 20.2% |
| 3 | PRO PHARMACEUTICALS GROUP | $4.4K | 3 | 15.5% |
| 4 | M/S. BILCARE GCS INC. | $4.3K | 4 | 15.2% |
| 5 | NEWLIFE MEDICALS (USA). INC. | $4.3K | 2 | 15.1% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from AUSTRALIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED | $14.3K | 8 | 50.7% |
| 2 | INDOCO REMEDIES LIMITED | $13.9K | 12 | 49.3% |
Import Statistics
- Import Value
- $28.2K
- Shipments
- 20
- Foreign Suppliers
- 5
- Indian Buyers
- 2
- Avg. Shipment
- $1.4K
Other Rivaroxaban Import Origins
Related Analysis
Frequently Asked Questions — Rivaroxaban Imports from AUSTRALIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Rivaroxaban suppliers from AUSTRALIA to India?
The top Rivaroxaban suppliers from AUSTRALIA to India include BILCARE GCS INC., PRO PHARMACEUTICALS GROUP PTY LTD, PRO PHARMACEUTICALS GROUP. The leading supplier is BILCARE GCS INC. with import value of $9.6K USD across 8 shipments. India imported Rivaroxaban worth $28.2K USD from AUSTRALIA in total across 20 shipments.
QHow much Rivaroxaban does India import from AUSTRALIA?
India imported Rivaroxaban worth $28.2K USD from AUSTRALIA across 20 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Rivaroxaban from AUSTRALIA?
The main Indian buyers of Rivaroxaban sourced from AUSTRALIA include MANKIND PHARMA LIMITED, INDOCO REMEDIES LIMITED. The largest buyer is MANKIND PHARMA LIMITED with $14.3K in imports across 8 shipments.
QWhat is the total value of Rivaroxaban imports from AUSTRALIA to India?
The total value of Rivaroxaban imports from AUSTRALIA to India is $28.2K USD, across 20 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: AUSTRALIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from AUSTRALIA and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $28.2K aggregated from 20 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
5 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists